|
|
Volumn 279, Issue 24, 1998, Pages 1936-1937
|
|
Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
BAY 12 9166;
FUMAGILLOL CHLOROACETYLCARBAMATE;
MATRIX METALLOPROTEINASE INHIBITOR;
MONOCLONAL ANTIBODY;
THALIDOMIDE;
THROMBOCYTE FACTOR;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
ANGIOGENESIS;
ANTINEOPLASTIC ACTIVITY;
CANCER RESEARCH;
CLINICAL TRIAL;
HUMAN;
MUSCULOSKELETAL DISEASE;
NONHUMAN;
NOTE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
REPRODUCTIVE TOXICITY;
TERATOGENICITY;
WOUND HEALING;
|
|
EID: 0032562950
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.279.24.1936-JMN0624-2-1 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|